Maxim Group Downgrades Coherus BioSciences to Hold
Portfolio Pulse from Benzinga Newsdesk
Maxim Group analyst Jason McCarthy has downgraded Coherus BioSciences from Buy to Hold.

November 08, 2023 | 4:21 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Coherus BioSciences has been downgraded from Buy to Hold by Maxim Group.
The downgrade from Buy to Hold by Maxim Group indicates a less optimistic outlook for Coherus BioSciences. This could potentially lead to a decrease in the stock price in the short term as investors may perceive this as a signal to sell or hold off on buying more shares.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100